Myriad Genetics (MYGN) Current Deferred Tax Assets: 2010-2015
Historic Current Deferred Tax Assets for Myriad Genetics (MYGN) over the last 5 years, with Sep 2015 value amounting to $13.5 million.
- Myriad Genetics' Current Deferred Tax Assets rose 2.05% to $13.5 million in Q3 2015 from the same period last year, while for Sep 2015 it was $13.5 million, marking a year-over-year increase of 2.05%. This contributed to the annual value of $13.5 million for FY2015, which is 107.69% up from last year.
- Per Myriad Genetics' latest filing, its Current Deferred Tax Assets stood at $13.5 million for Q3 2015, which was down 0.00% from $13.5 million recorded in Q2 2015.
- Myriad Genetics' Current Deferred Tax Assets' 5-year high stood at $13.5 million during Q2 2015, with a 5-year trough of $4.4 million in Q1 2011.
- Its 3-year average for Current Deferred Tax Assets is $10.3 million, with a median of $9.1 million in 2013.
- As far as peak fluctuations go, Myriad Genetics' Current Deferred Tax Assets crashed by 47.25% in 2011, and later skyrocketed by 107.69% in 2015.
- Quarterly analysis of 5 years shows Myriad Genetics' Current Deferred Tax Assets stood at $7.8 million in 2011, then climbed by 20.14% to $9.4 million in 2012, then dropped by 2.99% to $9.1 million in 2013, then spiked by 41.21% to $12.8 million in 2014, then grew by 2.05% to $13.5 million in 2015.
- Its Current Deferred Tax Assets stands at $13.5 million for Q3 2015, versus $13.5 million for Q2 2015 and $13.5 million for Q1 2015.